Anthem Biosciences IPO will hit the market on July 14, 2025, and closes on July 16, 2025. The Anthem Biosciences IPO GMP Kostak rate and subject to Sauda updated as of today. The Anthem Biosciences IPO Grey Market Premium has started with low premium rates at this time, but as some trending movement is possible soon, we need to wait for the rates to change with the market sentiment in a few days or to stabilize the rates. You can check Anthem Biosciences IPO subscription status here.
Anthem Biosciences Limited is an innovation-driven and technology-focused Contract Research, Development, and Manufacturing Organization (“CRDMO”) with fully integrated operations encompassing drug discovery, development, and manufacturing processes. The company manufactures specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars.
As of September 30 2024, the company had 196 projects: 170 discovery projects (284 synthesized molecules), 132 early phase projects, 16 late phase projects (10 late phase molecules), and 13 commercial manufacturing projects (API and intermediates for 10 commercialized molecules).
Anthem Biosciences IPO Issue size of ₹3395.00 Crores, via Offer For Sale of ₹3395.00 Crores and issue price band has been fixed at ₹540 to ₹570 Per Share. The Anthem Biosciences IPO will be listed on July 21, 2025, NSE and BSE.
What is Anthem Biosciences IPO GMP Today?
- The Anthem Biosciences IPO GMP Today Or Grey Market Premium is ₹143.
What is Anthem Biosciences IPO Kostak Rates Today?
- The Anthem Biosciences IPO Kostak rate is ₹0.
What is Anthem Biosciences IPO Subject to Sauda Price Today?
- The Anthem Biosciences IPO Subject to Sauda rates is ₹2800.
Anthem Biosciences IPO Approximately Returns?
- The Anthem Biosciences IPO’s approximate return is 25%, which can also change according to the Market Sentiment.
Anthem Biosciences IPO GMP Live, Kostak, & Subject :
| Date | GMP | Kostak | Subject |
| 18 Jul 2024 | ₹143  | ₹0 | ₹2800 |
| 17 Jul 2024 | ₹144 | ₹0 | ₹2800 |
| 16 Jul 2024 | ₹158  | ₹0 | ₹3200 |
| 15 Jul 2024 | ₹156 | ₹0 | ₹3100 |
| 14 Jul 2024 | ₹115 | ₹0 | ₹2300 |
| 13 Jul 2024 | ₹100 | ₹0 | ₹2000 |
| 12 Jul 2024 | ₹99 | ₹0 | ₹2000 |
| 11 Jul 2024 | ₹95 | ₹0 | ₹1900 |
| 10 Jul 2024 | ₹107 | ₹0 | ₹2200 |
| 09 Jul 2024 | ₹103 | ₹0 | ₹2100 |
| 08 Jul 2024 | ₹66 | ₹0 | ₹2000 |
IPO GMP Facts :
- The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
- The GMP is also likely to be higher for IPOs that are heavily subscribed.
- It is important to do your research before investing in an IPO, regardless of the GMP.
- The IPO GMP is estimated, considering market volatility, limited historical data, underwriting conditions, legal risks, and potential dilution.
IPO GMP Disclaimer :
- GMP is not an indicator of the final listing price: The GMP is just a reflection of the demand and supply of the IPO shares in the grey market. The final listing price will depend on a number of factors, including the overall market sentiment and the performance of the company in the post-IPO period.
- The GMP can be volatile: The GMP can fluctuate significantly in the days leading up to the IPO listing. This is due to the uncertainty surrounding the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the IPO shares will list at a profit. The final listing price could be lower than the GMP, or the shares could even Octline in value after listing.
- Investing in IPOs carries risks: IPOs are considered to be high-risk investments. There is always the possibility that the company could fail, or that the shares could be diluted in the future.
- Risk Factors: Identify and articulate the key risk factors that could impact the IPO GMP and subsequent trading of the company’s shares. These may include industry-specific risks, regulatory uncertainties, economic downturns, and competitive pressures.
Disclaimer: Stock Market Investments are Subject to Market risks, read all scheme Related Document Carefully Before Investing.